These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36115991)

  • 41. Harboyan syndrome: novel SLC4A11 mutation, clinical manifestations, and outcome of corneal transplantation.
    Tananuvat N; Tananuvat R; Chartapisak W; Mahanupab P; Hokierti C; Srikummool M; Kampuansai J; Intachai W; Olsen B; Ketudat Cairns JR; Kantaputra P
    J Hum Genet; 2021 Feb; 66(2):193-203. PubMed ID: 32884076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autosomal recessive corneal endothelial dystrophy (CHED2) is associated with mutations in SLC4A11.
    Jiao X; Sultana A; Garg P; Ramamurthy B; Vemuganti GK; Gangopadhyay N; Hejtmancik JF; Kannabiran C
    J Med Genet; 2007 Jan; 44(1):64-8. PubMed ID: 16825429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of mutations in the SLC4A11 gene in patients with recessive congenital hereditary endothelial dystrophy.
    Hemadevi B; Veitia RA; Srinivasan M; Arunkumar J; Prajna NV; Lesaffre C; Sundaresan P
    Arch Ophthalmol; 2008 May; 126(5):700-8. PubMed ID: 18474783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mice with a targeted disruption of Slc4a11 model the progressive corneal changes of congenital hereditary endothelial dystrophy.
    Han SB; Ang HP; Poh R; Chaurasia SS; Peh G; Liu J; Tan DT; Vithana EN; Mehta JS
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6179-89. PubMed ID: 23942972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A biochemical framework for SLC4A11, the plasma membrane protein defective in corneal dystrophies.
    Vilas GL; Morgan PE; Loganathan SK; Quon A; Casey JR
    Biochemistry; 2011 Mar; 50(12):2157-69. PubMed ID: 21288032
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical features and possible founder mutation of the 8bp duplication mutation in the SLC4A11 gene causing corneal dystrophy and perceptive deafness in three South American families.
    Romero PT; Donoso R; López P; Miranda A; Rodríguez L; Chrzanowsky D; Asenjo MS; Burgos G; Villegas P; Desir J; Moya G; Herrera LM
    Ophthalmic Genet; 2019 Apr; 40(2):91-98. PubMed ID: 30856043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High Throughput Assay Identifies Glafenine as a Corrector for the Folding Defect in Corneal Dystrophy-Causing Mutants of SLC4A11.
    Chiu AM; Mandziuk JJ; Loganathan SK; Alka K; Casey JR
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7739-53. PubMed ID: 26641551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exome Sequencing Reveals
    Yousaf K; Naz S; Mushtaq A; Wohler E; Sobreira N; Ho BM; Chen LJ; Chu WK; Bashir R
    Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833236
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SLC4A11 mutations in Fuchs endothelial corneal dystrophy.
    Vithana EN; Morgan PE; Ramprasad V; Tan DT; Yong VH; Venkataraman D; Venkatraman A; Yam GH; Nagasamy S; Law RW; Rajagopal R; Pang CP; Kumaramanickevel G; Casey JR; Aung T
    Hum Mol Genet; 2008 Mar; 17(5):656-66. PubMed ID: 18024964
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Congenital Corneal Endothelial Dystrophies Resulting From Novel De Novo Mutations.
    Cunnusamy K; Bowman CB; Beebe W; Gong X; Hogan RN; Mootha VV
    Cornea; 2016 Feb; 35(2):281-5. PubMed ID: 26619383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conditionally Immortal Slc4a11-/- Mouse Corneal Endothelial Cell Line Recapitulates Disrupted Glutaminolysis Seen in Slc4a11-/- Mouse Model.
    Zhang W; Ogando DG; Kim ET; Choi MJ; Li H; Tenessen JM; Bonanno JA
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3723-3731. PubMed ID: 28738416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Harboyan syndrome with biallelic SLC4A11 pathogenic variants misdiagnosed as congenital CMV infection.
    Loveridge-Easther C; Kiray G; Hull S; Vincent AL
    Ophthalmic Genet; 2022 Oct; 43(5):685-688. PubMed ID: 35672901
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biosynthetic and functional defects in newly identified SLC4A11 mutants and absence of COL8A2 mutations in Fuchs endothelial corneal dystrophy.
    Soumittra N; Loganathan SK; Madhavan D; Ramprasad VL; Arokiasamy T; Sumathi S; Karthiyayini T; Rachapalli SR; Kumaramanickavel G; Casey JR; Rajagopal R
    J Hum Genet; 2014 Aug; 59(8):444-53. PubMed ID: 25007886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detailed assessment of renal function in a proband with Harboyan syndrome caused by a novel homozygous SLC4A11 nonsense mutation.
    Liskova P; Dudakova L; Tesar V; Bednarova V; Kidorova J; Jirsova K; Davidson AE; Hardcastle AJ
    Ophthalmic Res; 2015; 53(1):30-5. PubMed ID: 25500497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Harboyan Syndrome: A Novel SLC4A11 Variant With Unique Genotype-Phenotype Correlation.
    Magan T; Hammersmith KM; Viaene AN; Kumar P; Eagle RC; Milman T
    Cornea; 2022 Aug; 41(8):1053-1057. PubMed ID: 35439766
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Energy Shortage in Human and Mouse Models of SLC4A11-Associated Corneal Endothelial Dystrophies.
    Zhang W; Frausto R; Chung DD; Griffis CG; Kao L; Chen A; Azimov R; Sampath AP; Kurtz I; Aldave AJ
    Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):39. PubMed ID: 32721020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subepithelial amyloid deposits in congenital hereditary endothelial dystrophy: a histopathologic study of five cases.
    Vemuganti GK; Sridhar MS; Edward DP; Singh S
    Cornea; 2002 Jul; 21(5):524-9. PubMed ID: 12072731
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oligomerization of SLC4A11 protein and the severity of FECD and CHED2 corneal dystrophies caused by SLC4A11 mutations.
    Vilas GL; Loganathan SK; Quon A; Sundaresan P; Vithana EN; Casey J
    Hum Mutat; 2012 Feb; 33(2):419-28. PubMed ID: 22072594
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mouse Slc4a11 expressed in Xenopus oocytes is an ideally selective H+/OH- conductance pathway that is stimulated by rises in intracellular and extracellular pH.
    Myers EJ; Marshall A; Jennings ML; Parker MD
    Am J Physiol Cell Physiol; 2016 Dec; 311(6):C945-C959. PubMed ID: 27681179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human SLC4A11-C functions as a DIDS-stimulatable H⁺(OH⁻) permeation pathway: partial correction of R109H mutant transport.
    Kao L; Azimov R; Abuladze N; Newman D; Kurtz I
    Am J Physiol Cell Physiol; 2015 Jan; 308(2):C176-88. PubMed ID: 25394471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.